KLIXAR Joins Health Decisions’ Global Network of CROs Advocating Higher Efficiency Standards
Latin American CRO is now a certified partner in Health Decisions’ Agile Clinical Network, dedicated to improving processes and systems across global trials
Durham, NC, November 20, 2009 --(PR.com)-- Health Decisions (www.HealthDec.com), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, welcomes Argentina-based CRO KLIXAR to its Agile Clinical Network—a newly launched community of research partners formed to eliminate the information gaps and prolonged timelines inherent to complex global studies. As a network member, KLIXAR will share key resources, best practices, and partnership opportunities with Health Decisions and like-minded CROs who have embraced Agile Clinical Development—a methodology which combines adaptive design with adaptive operations to cut trial timelines and increase transparency—as the key to efficient multinational trials.
To become a certified network partner, KLIXAR completed rigorous training in Agile Clinical Development techniques using Health Decisions’ internal system. Available externally for the first time, the training system covers every aspect of Agile trial management with an emphasis on impactful yet easy-to-implement adaptive operations. This training is mandatory for all Agile Clinical Network partners and ensures adherence to the stringent standards and guidelines demanded by global trials.
“We welcome the opportunity to partner with a leading U.S.-based CRO to ensure the highest quality deliverables for our sponsors,” said Enrique Gaubeca, Managing Director at KLIXAR. “Our alliance with Health Decisions will enable us to broaden our customer base while providing unparalleled efficiency and transparency to pharmaceutical companies in Latin America.”
In addition to continuing education in Agile Clinical Development and opportunities to collaborate on adaptive solutions for clinical operations and design, the alliance gives KLIXAR access to Health Decisions’ high-efficiency data management systems, biostatistics expertise, medical writers, advanced data collection tools, and real-time reporting capabilities. In return, Health Decisions has gained the opportunity to expand its Agile philosophy to the Latin American market by becoming aligned with KLIXAR’s infrastructure.
“Our expanded presence in Latin America offers numerous advantages for running clinical trials: a large population, a high percentage of treatment-naïve patients, qualified medical personnel, and well-established regulations,” said Rick Farris, Chief Operations Officer at Health Decisions. "We look forward to working with KLIXAR and all our Agile Clinical Network partners to raise the standards of efficiency for global clinical trials. By producing rapid, accurate results for our sponsors regardless of geographic boundaries, we hope to shape the future of drug development and improve the quality of health and living standards worldwide.”
To learn more about the Agile Clinical Network, please read the press release on our website: http://www.healthdec.com/page/international-cro-agile-training-press-release.
For more information, please contact Katie Hendrick, Marketing Specialist, by email at khendrick@HealthDec.com or by phone at +1.919.967.1111 x116.
About Health Decisions
Health Decisions (www.HealthDec.com) is a full-service, global clinical research organization (CRO) specializing in high-efficiency adaptive solutions. Through integrated technology and agile clinical development methods that apply adaptive principles to both trial design and operations, Health Decisions provides sponsors unprecedented transparency and control and produces results 10-40 percent faster than traditional approaches.
Health Decisions is headquartered in Durham, NC, with over twenty years of drug development experience in setting new standards of speed and accuracy for pharmaceutical, biotech and medical device companies in Phase I-IV trials across all major therapy areas. For more information, please visit the company's website at www.HealthDec.com.
About KLIXAR
KLIXAR is a locally owned Contract Research Organization (CRO) located in Latin America combining the advantages of an agile company with those of a big international one. We offer clinical drug development and consulting services (specializing in Phase II to IV) aimed to serve the needs of small to medium size clinical trials. Sponsors in the pharmaceutical and biotechnology industry as well as CROs with no local presence will benefit from our services.
Taking advantage of KLIXAR's organizational structure, the company is able to proactively manage expectations through creation of customized solutions to address sponsor needs. It is the aim of KLIXAR to provide optimal solutions to deliver quality service and achieve product development goals.
KLIXAR provides services in five (5) countries in South America (Argentina, Brazil, Chile, Colombia and Peru) and three (3) countries in Central America (Costa Rica, Guatemala and Panama). Our presence in Brazil and Chile is strengthened through a partnership with a local CRO to assure compliance with the local regulatory requirements.
###
To become a certified network partner, KLIXAR completed rigorous training in Agile Clinical Development techniques using Health Decisions’ internal system. Available externally for the first time, the training system covers every aspect of Agile trial management with an emphasis on impactful yet easy-to-implement adaptive operations. This training is mandatory for all Agile Clinical Network partners and ensures adherence to the stringent standards and guidelines demanded by global trials.
“We welcome the opportunity to partner with a leading U.S.-based CRO to ensure the highest quality deliverables for our sponsors,” said Enrique Gaubeca, Managing Director at KLIXAR. “Our alliance with Health Decisions will enable us to broaden our customer base while providing unparalleled efficiency and transparency to pharmaceutical companies in Latin America.”
In addition to continuing education in Agile Clinical Development and opportunities to collaborate on adaptive solutions for clinical operations and design, the alliance gives KLIXAR access to Health Decisions’ high-efficiency data management systems, biostatistics expertise, medical writers, advanced data collection tools, and real-time reporting capabilities. In return, Health Decisions has gained the opportunity to expand its Agile philosophy to the Latin American market by becoming aligned with KLIXAR’s infrastructure.
“Our expanded presence in Latin America offers numerous advantages for running clinical trials: a large population, a high percentage of treatment-naïve patients, qualified medical personnel, and well-established regulations,” said Rick Farris, Chief Operations Officer at Health Decisions. "We look forward to working with KLIXAR and all our Agile Clinical Network partners to raise the standards of efficiency for global clinical trials. By producing rapid, accurate results for our sponsors regardless of geographic boundaries, we hope to shape the future of drug development and improve the quality of health and living standards worldwide.”
To learn more about the Agile Clinical Network, please read the press release on our website: http://www.healthdec.com/page/international-cro-agile-training-press-release.
For more information, please contact Katie Hendrick, Marketing Specialist, by email at khendrick@HealthDec.com or by phone at +1.919.967.1111 x116.
About Health Decisions
Health Decisions (www.HealthDec.com) is a full-service, global clinical research organization (CRO) specializing in high-efficiency adaptive solutions. Through integrated technology and agile clinical development methods that apply adaptive principles to both trial design and operations, Health Decisions provides sponsors unprecedented transparency and control and produces results 10-40 percent faster than traditional approaches.
Health Decisions is headquartered in Durham, NC, with over twenty years of drug development experience in setting new standards of speed and accuracy for pharmaceutical, biotech and medical device companies in Phase I-IV trials across all major therapy areas. For more information, please visit the company's website at www.HealthDec.com.
About KLIXAR
KLIXAR is a locally owned Contract Research Organization (CRO) located in Latin America combining the advantages of an agile company with those of a big international one. We offer clinical drug development and consulting services (specializing in Phase II to IV) aimed to serve the needs of small to medium size clinical trials. Sponsors in the pharmaceutical and biotechnology industry as well as CROs with no local presence will benefit from our services.
Taking advantage of KLIXAR's organizational structure, the company is able to proactively manage expectations through creation of customized solutions to address sponsor needs. It is the aim of KLIXAR to provide optimal solutions to deliver quality service and achieve product development goals.
KLIXAR provides services in five (5) countries in South America (Argentina, Brazil, Chile, Colombia and Peru) and three (3) countries in Central America (Costa Rica, Guatemala and Panama). Our presence in Brazil and Chile is strengthened through a partnership with a local CRO to assure compliance with the local regulatory requirements.
###
Contact
Health Decisions
Katie Hendrick, Marketing Specialist
919-960-1111x116
www.HealthDec.com
Katie Hendrick, Marketing Specialist
919-960-1111x116
www.HealthDec.com
Contact
Categories